Filter your search
- $4,995.00 – $14,995.00Genetic Technology is one of the closest-watched areas in healthcare and in the past two years Kalorama Information has published major studies on different aspects of this market. This Kalorama Information Bundle consists of four major reports in biotech equipment: DNA Sequencing Equipment Markets: Markets, Forecasts, Sequencer Product Reviews and Company Profiles SNP Genotyping Markets: […]November 1, 2008$995.00 – $3,000.00Smoking cessation is among the most dynamic pharmaceutical markets, and one that is expected to grow despite economic conditions. More than 5 million deaths are attributed to nicotine each year. This has encouraged public health entities to pursue smoking cessation, and has driven development of smoking cessation products, both prescription and over the counter. The […]November 1, 2008$995.00 – $1,990.00At present the Middle East region constitutes as small percent of global pharmaceutical sales. However, ever-increasing populations and governmental healthcare reforms are likely to increase demand. These markets will be essential for pharmaceuticals companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for companies looking to capture a larger […]November 1, 2008$2,995.00 – $6,995.00Hernia repair is a standard part of general surgery, but nonetheless one that has been revolutionized by two events over the past decade and a half: the the development of tension-free and laparoscopic techniques and the use of prosthetic materials. Tension-free mesh-based repairs (eg, Lichtenstein, plug and patch) began to increase in number in the […]November 1, 2008$3,995.00 – $7,990.00It is the general consensus of scientists that cancer vaccines will become a reality. Overall the cancer treatment market continues to grow and this demand sets the stage for vaccine products. There are several promising vaccines: the propholactic Gardasil has created a pathway for new vaccine products. M-Vax, Ocon-Vax in late stage development and are […]November 1, 2008$2,500.00 – $5,000.00Dominated by Lab Corp and Quest, the clinical laboratory services market is growing as new competitors enter. An essential part of the health industry, it is estimated that approximately 80% of physician’s diagnoses are a result of laboratory tests. In addition to diagnosing patients, clinical lab testing is performed to evaluate disease progression, monitor drug […]November 1, 2008According to Kalorama’s experts, there is over a 40 billion dollar market for technology companies who can assist the healthcare industry meet its key challenges. This Kalorama Information Market Research Bundle, a combination of 7 Kalorama Information Market research reports – over 1200 pages of material., presents those opportunities, and details the areas Kalorama thinks […]October 1, 2008Kalorama Information has been watching medical device markets in 2008 and has produced several market research studies useful to companies operating in this market. To maximize market research dollars, we’ve assembled one PDF that contains eight critical research studies with market forecasts, product reviews, company profiles and other information regarding these markets The following medical […]October 1, 2008$3,500.00 – $7,000.00Driven by mounting market pressures, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry. Kalorama Information’s Outsourcing in Drug Development is the third edition of this […]October 1, 2008$2,995.00 – $6,995.00The strategic concept of HIV/AIDS diagnosis and therapy is one of the most complex that the healthcare industry has ever seen. In order to cope with the challenges and opportunities of HIV/AIDS diagnostics and therapeutics, companies must think on a global basis. In addition to the basic pathology and complications of HIV/AIDS, there are primarily […]October 1, 2008
